Axcelis Technologies
Mihir Bhuptani, Mourik Bhattacharjee, Aaron Ahmed, Rishi Manyam, Matthew Liuzza
Additional Help: Preston Young, Simran Seth, Richard Pilleul
TMT Sector
Premier academic organization for aspiring finance professionals.
Recommendation Summary
I rate Axcelis Technologies as a Buy for the following reasons:
2
|
Ticker: ACLS Market Capitalization: 4.1B Current Trading Price (3-18-2023): $125 Target Price: $167.1 Implied Upside: 33% |
Premier academic organization for aspiring finance professionals.
Industry: Semiconductor Manufacturing–Ion Implantation
The Semiconductor Manufacturing process is long and complex. One stage of this process is called ion implantation which is a doping method used in semiconductors that introduces impurities into a semiconductor wafer, enabling conductivity. This process offers advantages over other doping methods as it allows for optimal precision and control, helping to avoid damage. As a result, this niche vertical has rapidly grown over the last few years and has great potential in the future.
Sources: IBIS World, Gartner, ACLS Investor Presentation
3
Ion Implantation is a Niche, but Fast Growing Segment in the Broader Industry
Premier academic organization for aspiring finance professionals.
Industry Trends
Electrification of Vehicles
The Rise of IoT and 5G
Reshoring of Chip Manufacturing
Sources: Gartner, IBIS, Data Bridge Research
4
Premier academic organization for aspiring finance professionals.
Porter’s 5 Forces
Sources: ACLS 10k, IBIS World, Gartner
5
LOW
LOW
LOW
MEDIUM
MEDIUM
Threat of New Entrants
Threat of Substitutes
Industry Rivalry
Bargaining Power of Suppliers
Bargaining Power of Buyers
Premier academic organization for aspiring finance professionals.
Axcelis Technologies: Company Overview + Products
Sources: ACLS 10k, ACLS Investor Presentation
6
Product Breakdown
Axcelis Technologies designs, manufactures and services ion implantation used in the fabrication of semiconductor chips. Their Purion family of products offers the most innovative implanters available on the market today. They sell to leading semiconductor chip manufacturers worldwide. The ion implantation business represented 97.6% of their revenue.
Company Overview
Symbol: ACLS
Market Cap: 4.15B
Enterprise Value: 3.78B
Div Yield: 0
Current Share Price: 126.2
Revenue Growth Rate: 39% → 920M
EBITDA Margin: 23% → 233M
57% Return on Invested Capital
52 Wk Low/High: 46.41-136.38
Beta: 1.7
Key Metrics FY2022
Premier academic organization for aspiring finance professionals.
High Growth Market with Product Differentiation
Sources: ACLS 10k, ACLS Investor Presentation
7
Ion Implantation is a Superior Doping Method
Efficient Operations and Shareholder Friendly
Ribbon Method vs Focused Beam Method
Premier academic organization for aspiring finance professionals.
Risk Analysis
Sources: ACLS 10k
8
Situation
Mitigation
Geopolitical Tension
Cyclical Demand
Technological Competition
To limit Chinese access to chips, the U.S. imposed export controls to China, where some of their customers are based.
Chip demand fluctuates in relation to economic downturns. In poor economic conditions, consumers buy technological products in less quantity.
Currently, ACLS has had no issue obtaining licenses. Further, regulations have been for advanced logic chips, a small part of their portfolio.
Semiconductors have become a key component in numerous industrial applications, leaving the industry less vulnerable to single retail end markets
If Axcelis falls behind to their competitors and loses their technological edge, they will lose market share
Axcelis has obtained over 400 patents. Other competitors are not solely focused on ion implantation, adding more security to their moat.
Premier academic organization for aspiring finance professionals.
Comparable Companies Analysis
Sources: Net Advantage, Yahoo Finance, Mergent
9
Assumptions and Takeaway:
Premier academic organization for aspiring finance professionals.
Comparable Companies Analysis
Sources: Net Advantage, Yahoo Finance, Mergent
10
Assumptions and Takeaway:
Premier academic organization for aspiring finance professionals.
Return On Invested Capital
11
Takeaway:
Premier academic organization for aspiring finance professionals.
Discounted Cash Flow Assumptions
Sources: NetAdvantage, ACLS 10k
12
Assumptions:
Premier academic organization for aspiring finance professionals.
Target Price: 167.10
13
Conclusion
Premier academic organization for aspiring finance professionals.
Income Statement
14
Premier academic organization for aspiring finance professionals.
Balance Sheet
15
Premier academic organization for aspiring finance professionals.
Cash Flow Statement
16
Premier academic organization for aspiring finance professionals.